Objective: To determine the incidence of nasopharyngeal angiofibrome in therapeutic management and results according to the degree of commitment and technique. Work Research: We reviewed the clinical histories of 45 patients treated in our department from January of 2000 to December of 2011, whose pathology results were confirmed, of which 100% were men and 65% corresponded to the range of 16 years old to 30 years old, the highest percentage of patients was cataloged as Fisch 2 with 87%, followed by a state Fisch 1with 7.1%, while 51% of patients were submitted to endoscopic surgery, followed by 36% underwent facial degloving average, the complication was the most frequent intra-operative bleeding, constituting about 13% recurrences originated among the first 5 months and 1 year (2 patients), between 1 and 5 years (2 patients) and finally the appearance of the then five years surgery (3 patients), none of the patients in the service underwent preoperative embolization. Conclusion: The nasopharyngeal angiofibrome is a tumor characterized by epistaxis and nasal obstruction, whose surgical treatment is elected, the most widely used today is endoscopic surgery, the middle face degloving and Caldwell Luc or not combined endoscopic surgery only is used in case of a tumor is difficult to access and / or large size.